APP and Alzheimer disease: Young osteocyte-derived EVs (OCYyoung-EVs), obtained from osteocytes of young mice (2 months old) rather than old mice, have been shown to have a protective effect in AD through the bone-brain axis, leading to improved performance in spatial learning tests in APP/PS1 mice [180].